531681 — Amerise Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsSpeculativeMicro CapNeutral

Annual balance sheet for Amerise Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.184	0.251	0.193	0.13	0.136
Net Total Accounts Receivable
Net Total Receivables	44.7	0	0	62.2	0
Total Inventory
Total Other Current Assets
Total Current Assets	44.9	0.251	0.193	62.3	0.136
Net Property, Plant And Equipment	0	0	0	0	0
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	56	60.2	56.3	120	56.5
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.249	5.95	5.38	62.7	0.369
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	0.249	5.95	5.38	63.5	1.27
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	55.8	54.3	50.9	56.4	55.2
Total Liabilities & Shareholders' Equity	56	60.2	56.3	120	56.5
Total Common Shares Outstanding